ABOUT BIOSION

We are a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.

CORE STRENGTHS OF BIOSION
  • WORLD-CLASS TEAM
    Experienced global leaders from multinational companies who have brought more than 20 Innovative biologics to the market worldwide. Management team with proven track record of generating $5B+ in partnering R&D and commercial revenue.
  • PIPELINE AND DISCOVERY ENGINE
    Growing preclinical and clinical pipeline with greater than 10 programs. Proprietary platforms to create cutting edge biologics.
  • GLOBAL PARTNERSHIP
    Partnering business model to maximize portfolio value. Global Business Development and Alliance Management capabilities with 9 partnerships to date.
Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号
ABOUT BIOSION
We are a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases.
Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号